Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: A retrospective study

Transfusion

Volumn 47, Issue 1, 2007, Pages 55-58

  Killie, Mette Kjær ^a   Husebekk, Anne ^b   Kaplan, Cecile ^b   Taaning, Ellen ^b   Skogen, Bjørn ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ANTIGEN;

ALLOIMMUNITY; ARTICLE; CHILDBIRTH; DISEASE SEVERITY; HUMAN; MOTHER; QUANTITATIVE ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; AUTOANTIBODIES; DELIVERY, OBSTETRIC; FEMALE; HUMANS; INFANT, NEWBORN; ISOANTIBODIES; MEDICAL RECORDS; PLATELET COUNT; PREGNANCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 33845786071     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01063.x     Document Type: Article

References (13)

1. Mueller-Eckhardt C, Grubert A, WeisHeit M, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-7.
2. Kaplan C, Daffos E, Forestier F, et al. Current trends in neonatal alloimmune thrombocytopenia: diagnosis and therapy. In: Platelet immunology: fundamental and clinical aspects. Vol. 206. Paris: John Libby Eurotext, Colloque Inserm; 1991. p. 267-78.
3. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55.
4. Williamson LM, Hackett G, Rennie J, et al. The natural history of foetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1,Zwa) as determined by antenatal screening. Blood 1998;92:2280-7.
5. Jægtvik S, Husebekk A, Aune B, et al. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies: the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. Br J Obstet Gynecol 2000;107:691-4.
6. Radder CM, Kanai HH, Brand A. On the mechanism of high dose maternal intravenous immunoglobulin (IVIG) in alloimmune thrombocytopenia. In: Management of fetal alloimmune thrombocytopenia. Amsterdam: PrintPartners Ipskamp; 2004. p. 69-81.
7. Maslanka K, Guz K, Zupanska B. Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia. Vox Sang 2003;85:326-7.
8. Bessos H, Turner M, Urbaniak S. Is there a relationship between anti-HPA 1a concentration and severity of neonatal alloimmune thrombocytopenia? Immunhematology 2005;21:102-8.
9. Ni H, Chen P, Spring CM, et al. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenious IgG therapy. Blood 2006;107:2976-83.
10. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for identification of platelet-reactive antibodies. Blood 1987;70:1722-6.
11. Bertrand G, Jallu V, Gouet M, et al. Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure. Transfusion 2005;45:313.
12. Bessos H, Perez S, Armstrong-Fisher S, Urbaniak S, Turner M. The development of a quantitative ELISA for antibodies against platelet antigen type 1a. Transfusion 2003;43:350-6.
13. Killie MK, Kjeldsen-Kragh J, Skogen B, Husebekk A. Maternal anti-HPA 1a antibody level as predictive value in Neonatal alloimmune trombocytopenic purpura (NAITP) [abstract]. Blood 2004;104:2072.